Funded Tech Companies
Concert Pharmaceuticals
Wondering who provided funding to Concert Pharmaceuticals? Adage Capital Management, Brookside Capital and New Leaf Venture Partners joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Concert Pharmaceuticals
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
99 Hayden Ave. 500
Lexington, MA 02421
USA
Lexington, MA 02421
USA
Phone
Website
Email Address
Company Background Information
Overview
Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on applying its DCE Platform to create novel small molecule drugs.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/13/2014
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Roger Tung
Chief Financial Officer
Marc Becker
Chief Operating Officer
Nancy Stuart
VP - Bus. Development
James Cassella
Company Investors
- Adage Capital Management
- Brookside Capital
- New Leaf Venture Partners
- Skyline Ventures (Stephen Hoffman)
- Three Arch Partners (Wilfred Jaeger)
- Flagship Pioneering (Douglas Cole)
- TVM Capital (Jens Eckstein)
- Greylock Partners
- QVT Fund
- Skyline Ventures (John Freun)
- Three Arch Partners (Wilf Jaeger)
- TVM Capital (Stephen Hoffman)
- Skyline Ventures (John Freund)
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs